000 01201 a2200313 4500
005 20250514182457.0
264 0 _c20040330
008 200403s 0 0 eng d
022 _a1539-3704
024 7 _a10.7326/0003-4819-140-6-200403160-00027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCrowther, Mark A
245 0 0 _aRandomized trial of warfarin nomograms.
_h[electronic resource]
260 _bAnnals of internal medicine
_cMar 2004
300 _a490; author reply 491-2 p.
_bdigital
500 _aPublication Type: Comment; Comparative Study; Letter
650 0 4 _aAge Factors
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aHeparin, Low-Molecular-Weight
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInternational Normalized Ratio
650 0 4 _aPulmonary Embolism
_xdrug therapy
650 0 4 _aVenous Thrombosis
_xdrug therapy
650 0 4 _aWarfarin
_xadministration & dosage
700 1 _aHarrison, Linda
700 1 _aHirsh, Jack
773 0 _tAnnals of internal medicine
_gvol. 140
_gno. 6
_gp. 490; author reply 491-2
856 4 0 _uhttps://doi.org/10.7326/0003-4819-140-6-200403160-00027
_zAvailable from publisher's website
999 _c14742145
_d14742145